Cargando…
Barriers and facilitators to using aspirin for preventive therapy: a qualitative study exploring the views and experiences of people with Lynch syndrome and healthcare providers
BACKGROUND: The National Institute for Health and Care Excellence (NG151) recommends considering daily aspirin for people with Lynch syndrome to reduce colorectal cancer risk. However, deciding whether to initiate aspirin could be a complex decision for patients and their healthcare providers, as bo...
Autores principales: | Lloyd, Kelly E., Foy, Robbie, Hall, Louise H., Ziegler, Lucy, Green, Sophie M. C., Haider, Zainab F., Taylor, David G., MacKenzie, Mairead, Smith, Samuel G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396868/ https://www.ncbi.nlm.nih.gov/pubmed/35999639 http://dx.doi.org/10.1186/s13053-022-00235-z |
Ejemplares similares
-
GPs’ willingness to prescribe aspirin for cancer preventive therapy in Lynch syndrome: a factorial randomised trial investigating factors influencing decisions
por: Lloyd, Kelly E, et al.
Publicado: (2023) -
Aspirin use for cancer prevention: A systematic review of public, patient and healthcare provider attitudes and adherence behaviours
por: Lloyd, Kelly E., et al.
Publicado: (2022) -
General practitioner attitudes towards prescribing aspirin to carriers of Lynch Syndrome: findings from a national survey
por: Smith, Samuel G., et al.
Publicado: (2017) -
Lynch syndrome: barriers to and facilitators of screening and disease management
por: Watkins, Kathy E, et al.
Publicado: (2011) -
Effects of Aspirin on Colorectal Cancer Related to Lynch Syndrome
por: Beck,, Sarah Leilani
Publicado: (2012)